Document Detail

Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
MedLine Citation:
PMID:  19744259     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Cutaneous leishmaniasis (CL) is a disease caused by leishmania species. Intralesional sodium stibogluconate (SSG) has been considered the first line therapy for localized cutaneous leishmaniasis. There is still a need for more effective and less time-consuming therapeutic methods for this condition. OBJECTIVE: The aim of the present study was to investigate if the combination of intramuscular (IM) SSG or oral ketoconazole with intralesional (IL) SSG would be more effective than the intralesional SSG given alone in the treatment of localized cutaneous leishmaniasis. PATIENTS AND METHODS: Thirty patients with confirmed diagnosis of cutaneous leishmaniasis were included in the study. They were randomly assigned to three groups. The first group (10 patients with 12 lesions) was treated with intralesional SSG alone. The second group (10 patients with 15 lesions) was treated with the combination of intralesional SSG + intramuscular SSG. The third group (10 patients with 13 lesions) was treated with the combination of intralesional SSG and oral ketoconazole. A follow-up was performed every 4 weeks for a treatment period of 12 weeks, then monthly for a period of 6 months after the end of the treatment. RESULTS: Complete cure occurred in 58.3% of lesions in group 1, while 93.3% and 92.3% of lesions were cured in group 2 and 3 respectively. The difference between group 1 and the other groups was statistically significant (P < 0.05). CONCLUSION: Combined intramuscular SSG or oral ketoconazole with intralesional SSG is more effective than intralesional SSG alone for the treatment of CL. Oral ketoconazole is much easier and safer therapy than intramuscular SSG in combination with intralesional SSG in the treatment of localized cutaneous leishmaniasis.
M El-Sayed; A E Anwar
Related Documents :
18230039 - Adjuvant corticosteroid therapy for chronic disseminated candidiasis.
2663159 - Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinica...
6648619 - Cryptococcal meningitis: resolution eight months after antifungal therapy.
17990229 - An open-label comparative pilot study of oral voriconazole and itraconazole for long-te...
2229529 - Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis.
10919899 - Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment o...
9787369 - A randomized trial in patients inadequately controlled with timolol alone comparing the...
3780289 - An open study of sub-lingual buprenorphine in the treatment of chronic pain in the elde...
21445839 - Systemic bevacizumab (avastin) for exudative retinal detachment secondary to choroidal ...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2009-09-10
Journal Detail:
Title:  Journal of the European Academy of Dermatology and Venereology : JEADV     Volume:  24     ISSN:  1468-3083     ISO Abbreviation:  J Eur Acad Dermatol Venereol     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-05-14     Completed Date:  2010-10-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9216037     Medline TA:  J Eur Acad Dermatol Venereol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  335-40     Citation Subset:  IM    
Department of Dermatology & Venereology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Antifungal Agents / administration & dosage
Antimony Sodium Gluconate / administration & dosage*
Antiprotozoal Agents / administration & dosage
Dose-Response Relationship, Drug
Drug Therapy, Combination
Follow-Up Studies
Injections, Intralesional
Injections, Intramuscular
Ketoconazole / administration & dosage*
Leishmaniasis, Cutaneous / drug therapy*,  pathology
Middle Aged
Retrospective Studies
Skin / pathology
Time Factors
Treatment Outcome
Young Adult
Reg. No./Substance:
0/Antifungal Agents; 0/Antimony Sodium Gluconate; 0/Antiprotozoal Agents; 65277-42-1/Ketoconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Adnexal tumours of the skin as markers of cancer-prone syndromes.
Next Document:  The effect of an intervention aimed at reducing errors when administering medication through enteral...